SANUWAVE Health, Inc.
SNWV
$28.00
-$1.98-6.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 59.99% | 55.01% | 37.42% | 29.35% | 21.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.99% | 55.01% | 37.42% | 29.35% | 21.82% |
| Cost of Revenue | 33.95% | 57.09% | 47.10% | 35.11% | 39.31% |
| Gross Profit | 70.94% | 54.25% | 33.92% | 27.21% | 15.72% |
| SG&A Expenses | 30.21% | 2.40% | -12.20% | -29.46% | -32.25% |
| Depreciation & Amortization | 4.92% | 0.40% | -2.38% | -4.36% | -1.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.00% | 15.60% | 1.45% | -16.27% | -18.52% |
| Operating Income | 1,105.01% | 229.37% | 129.03% | 104.33% | 93.98% |
| Income Before Tax | -21.48% | 99.23% | 87.39% | 5.58% | -150.73% |
| Income Tax Expenses | 575.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Earnings from Continuing Operations | -21.56% | 99.22% | 87.37% | 5.57% | -150.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.56% | 99.22% | 87.37% | 5.57% | -150.72% |
| EBIT | 1,105.01% | 229.37% | 129.03% | 104.33% | 93.98% |
| EBITDA | 1,241.92% | 347.14% | 161.47% | 117.30% | 106.11% |
| EPS Basic | 56.78% | 100.80% | 81.63% | 15.82% | -143.90% |
| Normalized Basic EPS | 46.36% | 94.65% | 72.11% | 14.06% | -300.30% |
| EPS Diluted | 54.98% | 99.66% | 80.40% | 21.72% | -116.25% |
| Normalized Diluted EPS | 46.01% | 94.44% | 71.77% | 17.56% | -258.77% |
| Average Basic Shares Outstanding | 110.86% | 77.96% | 90.58% | 67.56% | 44.60% |
| Average Diluted Shares Outstanding | 117.32% | 85.79% | 99.54% | 45.90% | 25.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |